ARCH Venture Partners VIII, L.P. insider trades: Codiak BioSciences (CDAK) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where ARCH Venture Partners VIII, L.P. reports to the SEC
and 1 more company
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 13, 2022 | CDAK | ↑ Buy | 5,000,000 | $1.50 | $7.5M | Indirect | Sep 15, 2022 (2d) |
| Oct 16, 2020 | CDAK | ↑ Buy | 235,000 | $15.00 | $3.5M | Indirect | Oct 20, 2020 (4d) |
| Sep 18, 2020 | MTCR | ↑ Buy | 230,000 | $13.00 | $3.0M | Indirect | Sep 22, 2020 (4d) |
| Feb 22, 2019 | SNNA | ↑ Buy | 2,165,800 | $2.50 | $5.4M | Indirect | Feb 26, 2019 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About ARCH Venture Partners VIII, L.P.'s insider trades
ARCH Venture Partners VIII, L.P. is a 10% owner of Codiak BioSciences (CDAK). Since Feb 22, 2019, it has reported 4 open-market purchases worth $19.4M and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Its filings also include conversions (6 filings), other transactions (3 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CDAK insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.